Header cover image

Canadian (TSX) Biotech Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
  • 7D-1.4%
  • 3M35.8%
  • 1Y-3.9%
  • YTD4.6%

Over the last 7 days, the Biotech industry has dropped 1.4%, and Aptose Biosciences contributed the most with a 9.7% decline. However, the industry is down 3.9% over the past year.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Tue, 30 Nov 2021CA$5.8bCA$172.7m-CA$474,133,212.005.1x
Thu, 28 Oct 2021CA$8.0bCA$244.2m-CA$608,629,227.007.4x
Sat, 25 Sep 2021CA$8.2bCA$242.2m-CA$611,723,595.007.1x
Mon, 23 Aug 2021CA$5.0bCA$161.7m-CA$473,092,915.0828.2x
Sat, 10 Jul 2021CA$4.1bCA$161.7m-CA$473,575,158.0827.5x
Fri, 02 Apr 2021CA$4.7bCA$154.6m-CA$464,148,726.3123.3x
Mon, 04 Jan 2021CA$3.9bCA$64.1m-CA$334,671,817.2218.7x
Thu, 08 Oct 2020CA$4.3bCA$144.2m-CA$428,171,418.426.9x
Wed, 01 Jul 2020CA$3.9bCA$155.3m-CA$396,161,918.7988x
Sat, 04 Apr 2020CA$2.8bCA$154.4m-CA$340,999,386.67n/a
Tue, 07 Jan 2020CA$2.4bCA$162.2m-CA$239,728,365.87n/a
Mon, 30 Sep 2019CA$1.8bCA$164.5m-CA$237,615,972.87729.2x
Thu, 04 Jul 2019CA$2.0bCA$163.4m-CA$234,665,461.88n/a
Sun, 07 Apr 2019CA$1.9bCA$155.6m-CA$199,429,884.10181.2x
Wed, 09 Jan 2019CA$1.9bCA$175.8m-CA$198,156,362.4618x
PE Ratio


Total Market Cap: CA$2.0bTotal Earnings: -CA$177,380,159.45Total Revenue: CA$167.8m0%0%0%3 Year10 Year

Current Industry PE: There are only 2 profitable companies in this industry, so there is insufficient data to make an industry-wide assessment of PE.

Past Earnings Growth: The earnings for companies in the Biotechs industry have deteriorated over the last three years, while revenues have remained mostly flat. This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Canadian Biotech industry?


Industry PE: Investors are most optimistic about the Biotech industry even though it's trading below its 3-year average PE ratio of 112x. This is likely because analysts are expecting annual earnings growth of 15%, which is higher than its past year's earnings decline of 22% per year.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 15% over the next 5 years. This is better than its past earnings decline of 22% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

TRIL Trillium Therapeutics3.8%+CA$88.2m-0.9%PS45854.3x
MBX Microbix Biosystems7.1%+CA$6.5m87.5%PS6.2x
EDT Spectral Medical4.5%+CA$2.7m-38.7%PS29.8x
COV Covalon Technologies3.5%+CA$2.1m105.3%PS2.2x
VXL Vaxil Bio20.0%+CA$2.1m5.9%PB6.3x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News